Table 1 Summary of clinicopathologic characteristics of hepatocellular carcinoma patients enrolled in this study (n = 189)
Clinicopathologic characteristics | Value (%) |
|---|---|
Number of patients | 189 (100%) |
Mean age at surgery (years) | 64.6 (±10.78) |
Sex | |
Male | 148 (78.3%) |
Female | 41 (21.7%) |
Etiology | |
HBV | 151 (79.9%) |
HCV | 11 (5.8%) |
Alcohol | 10 (5.3%) |
Others | 17 (9.0%) |
Underlying liver disease | |
Cirrhosis | 165 (87.3%) |
Hepatitis | 18 (9.5%) |
Others | 6 (3.2%) |
BLCL stages | |
A | 101 (53.4%) |
B | 9 (4.8%) |
C | 79 (41.8%) |
Histologic grade | |
Grade 1 | 12 (6.3%) |
Grade 2 | 65 (34.4%) |
Grade 3 | 93 (49.2%) |
Grade 4 | 19 (10.1%) |
AJCC stages | |
I | 95 (50.3%) |
II | 69 (36.5%) |
III | 5 (2.6%) |
IV | 20 (10.6%) |
Child-Pugh class | |
A | 176 (93.1%) |
B | 13 (6.9%) |
AFPa | |
< 400 | 123 (65.1%) |
≥ 400 | 40 (21.2%) |
Surgical approach | |
Wedge resection | 41 (21.7%) |
Partial hepatectomy | 148 (78.3%) |
Additional treatments | |
None | 74 (39.1%) |
Systemic chemotherapy | 8 (4.2%) |
Radiofrequency ablation | 5 (2.6%) |
Transarterial chemoembolization | 90 (47.6%) |
Transplantation | 1 (0.5%) |
Combined (2 or 3 of above) | 11 (5.9%) |